Materials Select Sector

S&P 500

The Balanced Allocator

Comparable Companies - LIN

The insider data show 1 discretionary purchase and 7 discretionary sales in the past 12 months. The latest short interest is 1.3% of float with a days‑to‑cover of 1.9. The primary institutional holders are Vanguard Group Inc (9.6%), BlackRock Inc (7.9%) and State Street Corp (4.1%).

CHIEF EXECUTIVE OFFICER

SENIOR VICE PRESIDENT - APAC

EXEC VP & CHIEF LEGAL OFFICER

DIRECTOR

EXECUTIVE VP, NORTH AMERICA

EXECUTIVE VP, CHIEF HR OFFICER

Appointed to the additional role of Chairman of the Board following the retirement of Stephen F. Angel.

Chairman & Chief Executive Officer

Retired from the Linde Board of Directors after 25 years of service; currently serving as President and CEO of CSX Corporation.

Former Chairman of the Board

Promoted from Executive VP, North America to Chief Operating Officer to accelerate growth initiatives.

Executive VP & Chief Operating Officer

Continues in role as CFO; recently appointed to the Board of Directors of Stoke Space in December 2025.

Executive VP & Chief Financial Officer

Confirmed as Lead Independent Director in 2025/2026 leadership transition announcements.

Lead Independent Director

Transitioned from Lead Independent Director to Audit Committee Chair; Robert Wood now serves as Lead Independent Director.

Director & Audit Committee Chair

Retired from Linde after 33 years of service; succeeded by Binod Patwari.

Former Executive VP, APAC

Appointed to succeed John Panikar as the head of APAC operations.

Senior VP, APAC

Sanjiv Lamba

Matthew J. White

Sean F. Durbin

Robert L. Wood

Alberto Weisser

Paula Rosput Reynolds

Sanjiv Lamba represents the pinnacle of 'insider provenance' within the industrial gas sector, having spent over 35 years rising through the ranks of BOC and Linde. His career is defined by a successful turnaround of BOC India and the subsequent scaling of Linde’s APAC business into a primary growth engine. As CEO and now Chairman, Lamba has maintained a rigorous focus on margin expansion and return on capital (ROC), which reached 24.2% in 2025. His leadership style is deeply rooted in financial discipline and ethical governance, as evidenced by Linde's consistent recognition for business integrity. Lamba's dual role as Chairman and CEO reflects the Board's confidence in his ability to navigate complex global energy transitions while sustaining industry-leading shareholder returns.

Annual Shareholder Returns (Dividends & Buybacks)

Matthew J. White is a cornerstone of Linde’s post-merger financial stability, having served as the primary architect of the company’s capital allocation strategy since 2018. His background as an industrial engineer provides a unique 'operational-finance' lens, allowing him to manage large-scale capital programs with high efficiency. White’s tenure at Praxair and his subsequent role at Linde have been marked by consistent margin expansion and the successful integration of complex global supply chains. His recent appointment to the Stoke Space board signals a strategic broadening of his influence into deep-tech and high-growth industrial sectors, further solidifying his reputation as a versatile and forward-thinking executive.

Prof. DDr. Ann-Kristin Achleitner

Dr. Thomas Enders

Hugh Grant

Joe Kaeser

Dr. Victoria E. Ossadnik

Industrial gas and engineering company producing atmospheric and process gases, with a focus on clean energy projects and on-site gas supply.

Regional industrial gases business in the Americas.

Regional industrial gases business in Asia.

Regional industrial gases business in Europe.

Regional industrial gases business in the Middle East and India.

Corporate functions and other operations.

Global specialty materials company with four operating segments: Advanced Materials, Additives & Functional Products, Chemical Intermediates, and Fibers.

Produces and markets polymers, films, and plastics with differentiated performance properties for transportation, durables, electronics, building/construction, medical/pharma, and consumables.

Produces additives, coatings, and functional products for various applications including personal care, agriculture, and building/construction.

Produces commodity and specialty chemical intermediates, focusing on cost control, operational efficiency, and capacity utilization.

Produces acetate tow and fibers for textiles, leveraging proprietary cellulosic biopolymers and spinning technology.

Provides water, hygiene, and infection prevention solutions and services across four reportable segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences.

Water treatment and process solutions for industrial, commercial, and institutional customers.

Cleaning and sanitizing solutions for foodservice, hospitality, healthcare, and other industries.

Pest management services and digital solutions for commercial and residential customers.

Water purification, hygiene, and bioprocessing solutions for pharmaceutical, biotechnology, and healthcare industries.

Manufacturer and retailer of paint, coatings, and related products serving professional, industrial, commercial, and retail customers through three reportable segments.

Company-operated paint stores serving professional contractors, DIY customers, and commercial clients.

Manufactures and sells paint and coatings through mass merchandisers, home centers, and retailers.

Provides coatings for industrial, automotive, packaging, and marine applications globally.

Principal facilities include approximately 350 cryogenic and hydrogen plants in the Americas, 275 in EMEA, and 230 in APAC, five major pipeline complexes in North America, and engineering factories in Tacherting (Germany), Hesingue (France), New York (USA) and Dalian (China). Executive offices are leased in Woking (UK) and owned in Danbury (CT, USA); additional owned administrative spaces are in Tonawanda (NY, USA) and Pullach (Germany). The majority of production assets are owned; a small portion is leased.

Linde plc exemplifies a high-quality Mature_Compounder with 3% revenue growth to $33.99B in FY2025, operating margins at 26.4%, and OCF conversion 1.5x net income, driven by pricing, $10B backlog, and productivity; management under CEO Lamba excels in alignment (ROC/TSR incentives, personal buying) and track record (211% TSR), with strong capital returns ($22.6B buybacks, growing dividends) and board oversight, though tempered by modest incremental ROIC (5%) and rising leverage (1.7x net debt/EBITDA); this team is an exceptional match for compounding per-share value amid industrial gas moats.

Linde faces regulatory risks from current and potential GHG emission regulations, including carbon taxation and cap-and-trade programs in jurisdictions like California, China, Singapore, and the European Union. These regulations may increase capital, compliance, operating, and maintenance costs, and potentially decrease demand. The company mitigates these risks through commercial contracts, monitoring developments, evaluating business risks, maintaining contingency plans, and engaging experts. Physical risks from climate change are managed by plant design, operations, and risk management teams, with no anticipated material effects on plant operations.

As of December 31, 2025, Linde had 65,177 employees worldwide, comprised of approximately 28% women and 72% men. The workforce decreased by 112 employees from 2024, primarily due to cost reduction programs partially offset by acquisitions. The company has collective bargaining agreements covering approximately 200 union-represented employees in the U.S. Benefits include occupational pensions, health insurance contributions, and a U.S. Matching Gift Program for charitable contributions.

Linde's products and services must comply with relevant specifications to not adversely affect health, particularly for medical gases and healthcare services. Industrial gases are potentially hazardous, and defects or inadequate handling could lead to personal injuries, environmental damages, liability, and reputational harm. The company manages product liability risks through quality controls and compliance with regulations.

Linde engages in community initiatives, delivering over 800 community engagement projects globally in 2024, an increase of more than 30% from the prior year. The company supports charitable contributions through its U.S. Matching Gift Program, where employees can donate to tax-exempt organizations and receive matching contributions. Supplier finance programs facilitate participating suppliers' ability to finance payment obligations.

Revenue grew only 3% YoY to $33.99 bn in FY2025, operating margin rose 0.8 pp to 26.4%, and net debt jumped 31% to $21.9 bn, while a $1.55 bn impairment left tangible book value negative.

The 2025 CapEx program was directed toward capacity expansion for the record $10 bn backlog, including new air‑separation plants in Texas and Florida to support space‑launch and hydrogen projects, as well as incremental upgrades to existing network density. The transcript emphasizes that roughly half of the $6 bn total 2025 investment is tied to secured growth projects, with the remainder allocated to base‑plant maintenance and strategic clean‑energy initiatives.

The negative tangible book stems from a large impairment charge disclosed in the 2025 MD&A, though the auditor did not flag the impairment as a Critical Audit Matter. No other significant asset write‑downs or closures were reported, and the company continues to expand its plant footprint in Texas, Florida, and other strategic locations.

CapEx in FY2025 was directed toward capacity expansion for the backlog, space‑launch infrastructure, and hydrogen projects. The incremental ROIC of 5% indicates that these new projects are generating returns only modestly above the cost of capital, suggesting limited value creation beyond the core business.

Revolving credit facility - Five Year Credit Agreement

Revolving credit facility - 364-Day Credit Agreement

Other short-term bank borrowings (non-U.S.)

P/FCF

Guillermo Bichara

David Strauss

Chief Financial Officer

Executive VP & COO North America

Executive VP & Chief Legal Officer

David P. Strauss

Chief Human Resources Officer

Chief Executive Officer

Stephen F. Angel

Paula Reynolds

Sean Durbin

Re-appointment of directors

Ratification of independent auditor

Advisory and non-binding vote on named executive officer compensation

Advisory and non-binding vote on the frequency of future advisory shareholder votes on named executive officer compensation

Determine the price range at which the Company can re-allot shares acquired as treasury shares under Irish law

Shareholder proposal requesting an annual report regarding the alignment of the Company's direct and indirect lobbying activities with the Company's 2050 climate neutrality ambition

Denny Brown

Chief Information Officer

Karin Griggel

Chief Compliance Officer

Executive Officer

Juan Pelaez

Vice President of Investor Relations

Executive VP & CFO

CEO & Director

Chief Operating Officer & EVice President

Desiree Co Bacher

Senior VP & Chief Human Resources Officer

Kelcey E. Hoyt

Senior Vice President of FP&A and Sustainability & Chief Accounting Officer

Linde plc is a global industrial gases and engineering company that produces and distributes atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, acetylene). It also designs, engineers, and builds air-separation, hydrogen, synthesis-gas, olefin and natural-gas plants, providing turnkey production and processing services. The company operates worldwide on a geographic basis (Americas, EMEA, APAC) and grew through the 2018 merger of Linde AG and Praxair.

Industrial gases operations in the United States, Canada, Mexico and Brazil with approximately 350 cryogenic air-separation, hydrogen and CO2 plants and five major pipeline complexes.

Industrial gases operations in Germany, United Kingdom, France, Sweden, South Africa and other European, Middle-East and African countries with roughly 275 cryogenic plants and extensive pipeline and hydrogen facilities.

Industrial gases operations in China, Australia, India, South Korea and Thailand with about 230 cryogenic air-separation and CO2 plants and regional pipelines.

Designs and constructs turnkey process plants (air-separation, hydrogen, synthesis, olefin, natural-gas) for third-party customers worldwide, with manufacturing facilities in Germany, France, the United States and China.

Corporate costs and smaller businesses that do not meet quantitative thresholds for separate presentation.

Held base case revenue growth forecast, base case terminal multiple of 18.0x EBITDA, and WACC of 9.5% constant; solved backward from current stock price of 490.06.

Balance Sheet - Supplemental

Balance Sheet

Cash Flow Statement - Supplemental

Cash Flow Statement

Income Statement - Supplemental

Income Statement

Ratios

Valuation

Historical Ratios & Multiples - LIN

The specialty chemicals sector is currently in a cyclical trough. While Linde is outperforming peers like Eastman Chemical (which saw revenue decline 6.7%), it is not immune to the 4% volume decline in Europe. The industry is characterized by rational pricing, but volume growth is scarce.

Linde is relevant now because it has just completed a major leadership transition (Lamba to Chairman) while its valuation has reached a five-year high relative to its underlying growth rate.

Backlog Conversion Milestone: The conversion of $7 billion of the current $10 billion project backlog into active revenue by Q4 2026. This will validate whether the 'hydrogen hype' is translating into high-margin cash flow.

Linde's core value driver is its ability to pass through inflation via long-term contracts, but this is currently overshadowed by a valuation multiple that has decoupled from its 3% top-line growth. We expect a de-rating as the market realizes that record project backlogs of $10 billion are being offset by regional volume declines, such as the 4% drop in Europe during 2025. The downside is protected by a durable 4...

Moat Erosion via Energy Transition: If clean hydrogen projects fail to achieve the same 15-20 year lock-in and fixed-fee structures as traditional industrial gas, Linde's return profile will permanently impair.

The bear case models moat erosion and declining industrial volumes in Europe/China. The final Bear Case value of $287.69 is determined directly by the Bear Case DCF scenario.

Stewardship is high-quality but currently 'priced to perfection.' The governance outcome tree is as follows: 1. Status Quo: Lamba continues to use leverage to fund buybacks, sustaining the multiple until a macro shock occurs. 2. Strategic Pivot: Management slows buybacks to repair the balance sheet, leading to a multiple de-rating. 3. Growth Breakout: The $10B backlog converts faster than expected, justifying the...

Liquidation value analysis is not relevant for the company's archetype ('Mature_Compounder') and was not performed.

Linde plc reports Q1 2024 financial results with 10% EPS growth and 28.9% adjusted operating margin

Linde price target raised to $525 from $495 at Mizuho

BMO Capital Reiterates Outperform Rating on Linde (LIN)

Linde price target lowered to $490 from $540 at RBC Capital

Linde upgraded to Buy from Neutral at UBS

Seaport Global Securities Upgrades Linde (LIN) to Buy

Linde price target lowered to $495 from $520 at Mizuho

Linde price target lowered to $507 from $510 at UBS

Situation: Current price is $490.06 versus fair value $422.67 (-13.8% expected return), and valuation confidence is stable. Debate: Bull case depends on Backlog Conversion Milestone: The conversion of $7 billion of the current $10 billion project backlog into active revenue by Q4 2026. Bear case centers on Moat Erosion via Energy Transition: If clean hydrogen projects fail to achieve the same 15-20 year lock-in and fixed-fee structures as traditional industrial gas, Linde's return profile will permanently impair. Conclusion: Recommendation is Sell with no position, pending a materially better risk/reward setup.

Executive Summary

Linde's core value driver is its ability to pass through inflation via long-term contracts, but this is currently overshadowed by a valuation multiple that has decoupled from its 3% top-line growth. We expect a de-rating as the market realizes that record project backlogs of $10 billion are being offset by regional volume declines, such as the 4% drop in Europe during 2025. The downside is protected by a durable 48.8% gross margin, but the current entry price offers no margin of safety.<ul><li>Driver: Valuation Mean Reversion</li><li>Catalyst: Sustained industrial volume weakness in Europe and China</li><li>Protection: High switching-cost moat from on-site plants</li></ul>Our variant perception is based on time arbitrage. The market is pricing the stock for a breakout in clean energy and space launch applications, whereas our analysis of the capital structure and regional volume trends suggests the company is entering a phase of lower incremental returns. While the market sees a 'fortress balance sheet,' we see a 31% increase in net debt used to fund share repurchases at an EV/EBITDA multiple of 19.3x, which is at the top of its five-year historical range.This is a valuation-driven exit recommendation on a high-quality compounder where the price has significantly outpaced the compounding of per-share intrinsic value.

Core Investment Rationale

Linde operates as the world's largest industrial gas company, utilizing a 'Sale of Gas' model where it builds on-site plants for customers under 15-20 year take-or-pay contracts. This creates high switching costs and predictable cash flows. Revenue is split between merchant liquid (bulk delivery), packaged gases (cylinders), and on-site supply. Strategy is currently focused on 'profit prioritization,' utilizing pricing power to track globally weighted CPI and productivity initiatives to drive 30-50 basis points of annual margin expansion.The company's core assets are its intangible network density and physical infrastructure, including 855 cryogenic and hydrogen plants globally and five major pipeline complexes in North America. These assets support the production of atmospheric gases (oxygen, nitrogen, argon) and process gases (hydrogen, helium, carbon dioxide). The 'Linde' trademark and a portfolio of patents with staggered 20-year expirations form a secondary layer of protection, though management notes no single patent is material to the overall business.The industry is a rational oligopoly. Linde's $33.99 billion in 2025 revenue dwarfs its closest pure-play rival, Air Products (APD), which generated $12.21 billion. This scale allows Linde to maintain a 48.8% gross margin, which is 1,080 basis points higher than the peer median of 38.0%. Competition is focused on network density rather than price, with Linde currently investing $5.26 billion in CapEx (15.5% of revenue) to secure its lead in emerging sectors like hydrogen and space launch.Linde's recent history is defined by the successful 2018 merger with Praxair, which solidified its global leadership. Under CEO Sanjiv Lamba, the company has delivered consistent execution, with ROC reaching 24.2% in 2025. However, the current situation is marked by a significant leadership transition: Chairman Stephen F. Angel retired in January 2026, with Lamba assuming the dual role of Chairman and CEO. This consolidation of power occurs as the company faces a 'repair phase' in the capital cycle, where it is aggressively using debt to maintain shareholder returns despite a 1% decline in underlying sales in early 2024 and flat volumes in China and APAC.

Business & Situation

<ul><li>Bull Case: Linde's $10 billion project backlog and 90+ new gas application wins in decarbonization provide a clear path to volume recovery; the company's 48.8% gross margin proves it is a perfect stagflation hedge.</li><li>Bear Case: Net debt has ballooned to $21.9 billion while tangible book value turned negative ($1.55 billion); incremental ROIC of 5.0% suggests new growth projects are barely covering the cost of capital.</li></ul>The consensus view is that Linde is an 'all-weather' compounder that will be the primary beneficiary of the multi-trillion dollar hydrogen economy. This narrative has pushed the P/E multiple to 32.9x, even as revenue growth remains in the low single digits. Analysts are largely focused on the $10 billion backlog as a guarantee of future growth, ignoring the immediate headwinds in European industrial production.The specialty chemicals sector is currently in a cyclical trough. While Linde is outperforming peers like Eastman Chemical (which saw revenue decline 6.7%), it is not immune to the 4% volume decline in Europe. The industry is characterized by rational pricing, but volume growth is scarce.Our differentiated view is that the market is overestimating the 'quality' of recent earnings growth. While EPS grew 10% in early 2024, this was heavily supported by $22.6 billion in cumulative buybacks, a significant portion of which was funded by $15.1 billion in new debt issuance. The 'Mature Compounder' model is being stretched to its limit; the 5.0% incremental ROIC on $19.8 billion of cumulative CapEx is a clear signal that the moat is not generating the same returns on new capital as it did on legacy assets. Furthermore, the negative tangible book value of $1.55 billion following a large impairment suggests the asset base is less 'fortress-like' than management portrays.While Linde remains a world-class business, the current valuation requires a level of volume acceleration that is not supported by regional industrial data. At 19.3x EV/EBITDA, there is no room for execution error in the $10 billion backlog.Our analytical edge comes from a deeper appreciation of the company's deteriorating capital efficiency. By isolating the 5.0% incremental ROIC against the 13.4% base ROIC, we identify a 'fading' return profile that the market's trailing multiples fail to capture.

Core Thesis

CEO Sanjiv Lamba has an exceptional 35-year track record, including a successful turnaround of BOC India (2001-2005) and delivering a 211% five-year TSR at Linde. However, the recent retirement of Chairman Stephen Angel in January 2026 and Lamba's move to the dual Chairman/CEO role reduces board independence at a critical juncture.Skill is strong but increasingly aggressive. Management returned $7.4 billion to shareholders in 2025, but this was partially funded by a 31% increase in net debt. Historical buybacks have been effective, with trade ROIs reaching 88.8% on 2021 purchases, but recent timing scores (2/100 in late 2025) suggest less discipline at current price levels.Management maintains high credibility, hitting quarterly EPS estimates in 19 of the last 19 quarters. However, the 0/5 annual EPS hit rate suggests a tendency toward conservative initial guidance that is 'walked up' throughout the year.<ul><li>Board Independence: 91% (10 of 11 directors are independent)</li><li>Chairman/CEO Roles: Combined (as of Jan 2026)</li><li>Chairman Tenure: Less than 1 year (Lamba)</li><li>Insider Ownership: 0.21% (CEO holds 90,794 shares)</li><li>Shareholder Rights: Majority Voting, Clawback Policy, No Poison Pill</li></ul>Stewardship is high-quality but currently 'priced to perfection.' The governance outcome tree is as follows: 1. Status Quo: Lamba continues to use leverage to fund buybacks, sustaining the multiple until a macro shock occurs. 2. Strategic Pivot: Management slows buybacks to repair the balance sheet, leading to a multiple de-rating. 3. Growth Breakout: The $10B backlog converts faster than expected, justifying the current price. We believe Scenario 2 is the most likely as net debt/EBITDA approaches 2.0x.

Leadership & Governance

The valuation floor is anchored to the Bear Case DCF value of $287.69, which models a permanent erosion of the company's moat, 1.5% revenue growth, and margin compression to 24.0%.The base case assumes 4.1% revenue growth and operating margins expanding to 27.6% by Year 3, driven by backlog conversion and CPI-linked pricing. This yields a value of $395.77.The bull case models a breakout in hydrogen and space launch, with 5.0% revenue growth and 29.0% margins. Blue-Sky Potential: $467.76.The bear case models moat erosion and declining industrial volumes in Europe/China. The final Bear Case value of $287.69 is determined directly by the Bear Case DCF scenario.

Valuation Context

<ul><li>Backlog Conversion Milestone: The conversion of $7 billion of the current $10 billion project backlog into active revenue by Q4 2026. This will validate whether the 'hydrogen hype' is translating into high-margin cash flow.</li><li>Linde's core value driver is its ability to pass through inflation via long-term contracts, but this is currently overshadowed by a valuation multiple that has decoupled from its 3% top-line growth. We expect a de-rating as the market realizes that record project backlogs of $10 billion are being offset by regional volume declines, such as the 4% drop in Europe during 2025. The downside is protected by a durable 4...</li><li>Linde is relevant now because it has just completed a major leadership transition (Lamba to Chairman) while its valuation has reached a five-year high relative to its underlying growth rate.</li></ul>Linde is relevant now because it has just completed a major leadership transition (Lamba to Chairman) while its valuation has reached a five-year high relative to its underlying growth rate.

Catalyst Path & Context

<ul><li>Moat Erosion via Energy Transition: If clean hydrogen projects fail to achieve the same 15-20 year lock-in and fixed-fee structures as traditional industrial gas, Linde's return profile will permanently impair. Incremental ROIC has already fallen to 5.0%, suggesting new projects are less profitable than the legacy base.</li><li>The bear case models moat erosion and declining industrial volumes in Europe/China. The final Bear Case value of $287.69 is determined directly by the Bear Case DCF scenario. Risk monitor: Current price $490.06 vs fair value $422.67, expected return -13.8%.</li><li>Stewardship is high-quality but currently 'priced to perfection.' The governance outcome tree is as follows: 1. Status Quo: Lamba continues to use leverage to fund buybacks, sustaining the multiple until a macro shock occurs. 2. Strategic Pivot: Management slows buybacks to repair the balance sheet, leading to a multiple de-rating. 3. Growth Breakout: The $10B backlog converts faster than expected, justifying the... Risk monitor: Current price $490.06 vs fair value $422.67, expected return -13.8%.</li></ul>

Primary Risks

<ul><li>Entry Target: No new entries: recommendation is Sell.</li><li>Stop Loss: No stop-loss needed because recommendation is Sell (no position).</li><li>Position Size: Position size is None under current recommendation and risk constraints.</li><li>Time Horizon: N/A for a Sell recommendation.</li></ul><ul><li>Management stated in the Q4 2025 call that $2.5-$3.0 billion of projects are expected to start up in 2026.</li><li>Monitoring trigger: Current price $490.06 vs fair value $422.67, expected return -13.8%.</li><li>Incremental ROIC has already fallen to 5.0%, suggesting new projects are less profitable than the legacy base.</li></ul>A material acceleration in organic volume growth (>5%) in Europe and China that justifies the current 32.9x P/E multiple. Also require valuation reliability to improve before re-entering.

Actionable Parameters & Monitoring

LIN appears overvalued (fair value $422.67 vs current $490.06, expected return -13.8%). Recommendation: Sell; do not allocate until valuation and risk profile reset.

Final Conclusion

Driver

Sustained industrial volume weakness in Europe and China

Catalyst

High switching-cost moat from on-site plants

Protection

Linde's $10 billion project backlog and 90+ new gas application wins in decarbonization provide a clear path to volume recovery; the company's 48.8% gross margin proves it is a perfect stagflation hedge.

Bull Case

Net debt has ballooned to $21.9 billion while tangible book value turned negative ($1.55 billion); incremental ROIC of 5.0% suggests new growth projects are barely covering the cost of capital.

Bear Case

Situation: Current price is $490.06 versus fair value $422.67 (-13.8% expected return), and valuation confidence is stable. Debate: Bull case depends on Backlog Conversion Milestone: The conversion of $7 billion of the current $10 billion project backlog into active revenue by Q4 2026. Bear case centers on Moat Erosion via Energy Transition: If clean hydrogen projects fail to achieve the same 15-20 year lock-in and fixed-fee structures as traditional industrial gas, Linde's return profile will permanently impair. Conclusion: Recommendation is Sell with no position, pending a materially better risk/reward setup.

The strategy evolved from a defensive, self-help focus on pruning, network density, and backlog quality in FY2024 to a balanced approach in FY2025 that integrates clean energy/space secular growth with proactive restructuring to align costs for 2026.

Method	Implied Value	Weight	Weighted Value
DCF	$397.55	50%	$198.78
Comps	$459.95	30%	$137.98
Historicals	$429.55	20%	$85.91
Total Weighted			$422.67

LIN

Company Overview

Price History